Isolation and Characterization of Human Mesenchymal Stem Cells Derived From Synovial Fluid in Patients With Osteochondral Lesion of the Talus

The American Journal of Sports Medicine

Volumn 43, Issue 2, 2015, Pages 399-406

  Kim, Yong Sang ^a   Lee, ho Jin ^a   Yeo, Jee Eun ^a   Kim, Yong Il ^a   Choi, Yun Jin ^a   Koh, Yong Gon ^a  

^a Yonsei Sarang Hospital   (South Korea)

Author keywords

mesenchymal stem cell; osteochondral lesion of the talus; synovial fluid

Indexed keywords

C2ORF40 PROTEIN, HUMAN; CALCIUM BINDING PROTEIN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; MESSENGER RNA; OGN PROTEIN, HUMAN; ONCOPROTEIN; PRELP PROTEIN, HUMAN; SCLEROPROTEIN; SFRP4 PROTEIN, HUMAN; SIGNAL PEPTIDE; SMOC2 PROTEIN, HUMAN; TRANSCRIPTOME; TUMOR PROTEIN;

ADIPOSE TISSUE; ADULT; ANKLE; ARTICULAR CARTILAGE; BONE MARROW CELL; CARTILAGE CELL; CELL DIFFERENTIATION; CFU COUNTING; CYTOLOGY; FEMALE; GENETICS; HUMAN; MALE; MESENCHYMAL STROMA CELL; METABOLISM; MIDDLE AGED; PATHOLOGY; SYNOVIAL FLUID; SYNOVIUM; TALUS; YOUNG ADULT;

ADIPOSE TISSUE; ADULT; ANKLE JOINT; ANTIGENS, CD; BONE MARROW CELLS; CALCIUM-BINDING PROTEINS; CARTILAGE, ARTICULAR; CELL DIFFERENTIATION; CHONDROCYTES; COLONY-FORMING UNITS ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; NEOPLASM PROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TALUS; TRANSCRIPTOME; YOUNG ADULT;

EID: 84922189736     PISSN: 03635465     EISSN: 15523365     Source Type: Journal    
DOI: 10.1177/0363546514559822     Document Type: Article

References (36)

1. The authors declared that they have no conflicts of interest in the authorship and publication of this contribution.
2. Adachi N Sato K Usas A, et al. Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. J Rheumatol. 2002; 29: 1920-1930.
3. Asakura A Komaki M Rudnicki M. Muscle satellite cells are multipotential stem cells that exhibit myogenic, osteogenic, and adipogenic differentiation. Differentiation. 2001; 68: 245-253.
4. Barbero A Grogan S Schafer D Heberer M Mainil-Varlet P Martin I. Age related changes in human articular chondrocyte yield, proliferation and post-expansion chondrogenic capacity. Osteoarthritis Cartilage. 2004; 12: 476-484.
5. Barbero A Ploegert S Heberer M Martin I. Plasticity of clonal populations of dedifferentiated adult human articular chondrocytes. Arthritis Rheum. 2003; 48: 1315-1325.
6. Bertolo A Mehr M Janner-Jametti T, et al. An in vitro expansion score for tissue-engineering applications with human bone marrow-derived mesenchymal stem cells [published online April 10, 2013]. J Tissue Eng Regen Med. doi: 10.1002/term.1734.
7. Choi WJ Choi GW Kim JS Lee JW. Prognostic significance of the containment and location of osteochondral lesions of the talus: independent adverse outcomes associated with uncontained lesions of the talar shoulder. Am J Sports Med. 2013; 41: 126-133.
8. De Bari C Dell-Accio F Tylzanowski P Luyten F.P., Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum. 2001; 44: 1928-1942.
9. Dominici M Le Blanc K Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-317.
10. Ferkel RD Cheng JC. Ankle and subtalar arthroscopy. In: KelikianA, ed. Operative Treatment of the Foot and Ankle. New York: Appleton-Croft, 1999: 321.
11. Fernandes JC Martel-Pelletier J Pelletier JP. The role of cytokines in osteoarthritis pathophysiology. Biorheology. 2002; 39: 237-246.
12. Galois L Freyria AM Herbage D Mainard D. Cartilage tissue engineering: state-of-the-art and future approaches [in French]. Pathol Biol (Paris). 2005; 53: 590-598.
13. Gelse K von der Mark K Aigner T Park J Schneider H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum. 2003; 48: 430-441.
14. Giannini S Buda R Faldini C, et al. Surgical treatment of osteochondral lesions of the talus in young active patients. J Bone Joint Surg Am. 2005; 87(suppl 2):28-41.
15. Hayes AJ MacPherson S Morrison H Dowthwaite G Archer CW. The development of articular cartilage: evidence for an appositional growth mechanism. Anat Embryol (Berl). 2001; 203: 469-479.
16. Hegewald AA Ringe J Bartel J, et al. Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary study. Tissue Cell. 2004; 36: 431-438.
17. Hunziker EB Rosenberg LC. Repair of partial-thickness defects in articular cartilage: cell recruitment from the synovial membrane. J Bone Joint Surg Am. 1996; 78: 721-733.
18. Jones EA Crawford A English A, et al. Synovial fluid mesenchymal stem cells in health and early osteoarthritis: detection and functional evaluation at the single-cell level. Arthritis Rheum. 2008; 58: 1731-1740.
19. Kim YS Park EH Kim YC Koh YG. Clinical outcomes of mesenchymal stem cell injection with arthroscopic treatment in older patients with osteochondral lesions of the talus. Am J Sports Med. 2013; 41: 1090-1099.
20. Koga H Muneta T Nagase T, et al. Comparison of mesenchymal tissues-derived stem cells for in vivo chondrogenesis: suitable conditions for cell therapy of cartilage defects in rabbit. Cell Tissue Res. 2008; 333: 207-215.
21. Kono M Takao M Naito K Uchio Y Ochi M. Retrograde drilling for osteochondral lesions of the talar dome. Am J Sports Med. 2006; 34: 1450-1456.
22. Koyama N Okubo Y Nakao K Osawa K Fujimura K Bessho K. Pluripotency of mesenchymal cells derived from synovial fluid in patients with temporomandibular joint disorder. Life Sci. 2011; 89: 741-747.
23. Lee DH Sonn CH Han SB Oh Y Lee KM Lee SH. Synovial fluid CD34(-) CD44(+) CD90(+) mesenchymal stem cell levels are associated with the severity of primary knee osteoarthritis. Osteoarthritis Cartilage. 2012; 20: 106-109.
24. Mochizuki T Muneta T Sakaguchi Y, et al. Higher chondrogenic potential of fibrous synovium- and adipose synovium-derived cells compared with subcutaneous fat-derived cells: distinguishing properties of mesenchymal stem cells in humans. Arthritis Rheum. 2006; 54: 843-853.
25. Morito T Muneta T Hara K, et al. Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans. Rheumatology (Oxford). 2008; 47: 1137-1143.
26. Nagase T Muneta T Ju YJ, et al. Analysis of the chondrogenic potential of human synovial stem cells according to harvest site and culture parameters in knees with medial compartment osteoarthritis. Arthritis Rheum. 2008; 58: 1389-1398.
27. Oreffo RO Cooper C Mason C Clements M. Mesenchymal stem cells: lineage, plasticity, and skeletal therapeutic potential. Stem Cell Rev. 2005; 1: 169-178.
28. Pittenger MF Mackay AM Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147.
29. Sakaguchi Y Sekiya I Yagishita K Ichinose S Shinomiya K Muneta T. Suspended cells from trabecular bone by collagenase digestion become virtually identical to mesenchymal stem cells obtained from marrow aspirates. Blood. 2004; 104: 2728-2735.
30. Sakaguchi Y Sekiya I Yagishita K Muneta T. Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source. Arthritis Rheum. 2005; 52: 2521-2529.
31. Segawa Y Muneta T Makino H, et al. Mesenchymal stem cells derived from synovium, meniscus, anterior cruciate ligament, and articular chondrocytes share similar gene expression profiles. J Orthop Res. 2009; 27: 435-441.
32. Sekiya I Larson BL Vuoristo JT Reger RL Prockop DJ. Comparison of effect of BMP-2, -4, and -6 on in vitro cartilage formation of human adult stem cells from bone marrow stroma. Cell Tissue Res. 2005; 320: 269-276.
33. Sekiya I Ojima M Suzuki S, et al. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J Orthop Res. 2012; 30: 943-949.
34. Wakitani S Goto T Pineda SJ, et al. Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage. J Bone Joint Surg Am. 1994; 76: 579-592.
35. Zhang S Muneta T Morito T Mochizuki T Sekiya I. Autologous synovial fluid enhances migration of mesenchymal stem cells from synovium of osteoarthritis patients in tissue culture system. J Orthop Res. 2008; 26: 1413-1418.
36. Zuk PA Zhu M Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell. 2002; 13: 4279-4295.